Inhibrx Biosciences Acquisition Completion
Resolves: Acquisition closes and is completed.
sec_filing· M&A
Inhibrx Biosciences Acquisition Completion
Market overview
Derived from Inhibrx Biosciences, Inc. (INBX) (CIK 0002007919) 8-K filing analysis
M&A prediction market
- Implied probability (Yes)
- 85%
- Closes
- 2026-12-31
About this prediction
Resolution criteria
Acquisition closes and is completed.
More M&A markets
- ORRF announces a new acquisition target — 20% Yes
- Goldman Sachs closes $5B acquisition of fintech platform by Q4 2026 — 60% Yes
- Sabre completes acquisition of Red Owl Analytics — 75% Yes
- Danaher announces acquisition > $1B by mid-2027 — 45% Yes
- Acquisition Speculation — 20% Yes
- Announcement of post-merger integration details — 60% Yes
- FIBK Merger Completion — 75% Yes
- Spruce Power Merger Completion — 75% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…